Intersectional Stigma Reduction for Tajik Migrants Who Inject Drugs

减少注射毒品的塔吉克移民的跨部门耻辱

基本信息

  • 批准号:
    10755435
  • 负责人:
  • 金额:
    $ 17.81万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2023
  • 资助国家:
    美国
  • 起止时间:
    2023-08-04 至 2026-03-31
  • 项目状态:
    未结题

项目摘要

Project Summary Labor migration is a major contributor to fueling the global AIDS epidemic and also the movement of HIV across country borders and populations. Migrants who inject drugs while in a host country are at especially high risk. Tajikistan, a small country in Central Asia, exports more than a million temporary labor migrants annually, many of whom inject drugs. These migrants are highly subject to the negative effects of intersectional stigma within Russia's cultural and socio-economic environment due to being both a migrant worker and a person who injects drugs (PWID). In addition, they are subject to extensive censure and marginalization from their non-drug-using Tajik peers in the close-knit diaspora communities in which they reside, especially if they acquire HIV. The adverse effects of stigmatization on those who experience it are well documented. The intersection of stigmatized identities as migrants and people who inject drugs (PWID), along with stigma associated with HIV infection, contributes to HIV risk behavior, poses as a barrier to accessing HIV testing and other prevention/treatment services, and results in poorer health outcomes for those living with HIV. The proposed study will investigate the character of stigma in the Moscow Tajik migrant community, and the effects of multiple intersecting forms of stigma on the health and well-being of Tajik labor migrants who inject drugs while living in Moscow (Aim 1). We will use the insight and findings gained through this formative research to develop an innovative intervention specifically designed to counter the negative effects of drug- related stigma within the Tajik migrant community that can affect HIV risk behavior and prevention among Tajik migrants in Moscow who inject drugs (Aim 2). The Stigma Reduction Intervention Approach Via Leaders of Diaspora (SRI-AVLOD) intervention will draw on the strengths of close-knit Tajik diaspora communities in which new norms and behaviors can be effectively diffused and promoted within and across migrant social networks if endorsed by leaders whom they trust. SRI-AVLOD is designed to recruit and train Tajik diaspora community leaders as agents of change and open up conversation within the Moscow Tajik community about the effects of drug and HIV-related stigma, to reduce stigmatizing beliefs and actions that negatively affect HIV risk behavior and prevention among community members who inject drugs. After developing a working prototype, we will deliver the intervention to small groups of Tajik migrant community leaders to assess its feasibility and acceptability, and need for further modifications (Aim 3). In future work we will deliver and test the efficacy of the SRI-AVLOD model in changing drug-related stigma and stigmatizing beliefs, behavior, and consequences at all levels (community, leadership, PWID) within the Tajik diaspora community and its positive effects in reducing HIV risk behavior and increasing the adoption of HIV prevention methods and services among its Tajik members who inject drugs.
项目摘要 劳动迁移是助长全球艾滋病流行和艾滋病毒运动的主要因素 跨国边界和人口。尤其是在东道国注射毒品的移民尤其是 高风险。塔吉克斯坦(Tajikistan 每年,其中许多人注入毒品。这些移民高度受到相交的负面影响 俄罗斯文化和社会经济环境中的污名既是移民工人又是一个 注射毒品的人(PWID)。此外,它们受到广泛的谴责和边缘化的影响 他们在居住的密友侨民社区中的非毒品的塔吉克同龄人,尤其是当他们 获取艾滋病毒。污名化对经历的人的不利影响已得到充分记录。这 作为移民和注入毒品的人(PWID)的污名化身份的交集以及污名 与艾滋病毒感染相关,有助于艾滋病毒的风险行为,作为进入艾滋病毒测试的障碍和 其他预防/治疗服务,并导致艾滋病毒患者的健康状况较差。 拟议的研究将调查莫斯科塔吉克移民社区中的污名特征, 以及多种相交形式的污名对塔吉克劳工移民健康和福祉的影响 居住在莫斯科时注入药物(AIM 1)。我们将使用这种形成性的见解和发现 研究以开发专门设计的创新干预措施,以应对药物的负面影响 塔吉克移民社区内的相关污名可能会影响塔吉克的艾滋病毒风险行为和预防 莫斯科的移民注射毒品(AIM 2)。通过领导者的污名降低干预方法 侨民(Sri-Avlod)干预将借鉴紧密联系的塔吉克侨民的优势 哪些新规范和行为可以有效地扩散和促进移民社会的内部和促进 网络如果他们信任的领导者认可。 Sri-avlod旨在招募和训练塔吉克侨民 社区领导人是变革的代理商,并在莫斯科塔吉克社区内开放对话 药物和与HIV相关的污名的影响,减少对艾滋病毒产生负面影响的污名化信念和行动 注射毒品的社区成员之间的风险行为和预防。在开发工作后 原型,我们将向塔吉克移民社区领导人的小组进行干预,以评估其 可行性和可接受性,并需要进一步修改(AIM 3)。 在未来的工作中,我们将传递和测试SRI-Avlod模型在变化与药物有关的功效 在各个层面(社区,领导力,pwid)的污名和污名化的信念,行为和后果 在塔吉克侨民社区及其在降低艾滋病毒风险行为并增加的积极影响 在注射毒品的塔吉克成员中采用艾滋病毒预防方法和服务。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Mahbat Bahromov其他文献

Mahbat Bahromov的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Mahbat Bahromov', 18)}}的其他基金

Scaling-Up Stepped Care for Women's Mental Health in Primary Care in an LMIC
在中低收入国家的初级保健中扩大对妇女心理健康的分级护理
  • 批准号:
    10477040
  • 财政年份:
    2019
  • 资助金额:
    $ 17.81万
  • 项目类别:
Scaling-Up Stepped Care for Women's Mental Health in Primary Care in an LMIC
在中低收入国家的初级保健中扩大对妇女心理健康的分级护理
  • 批准号:
    10247042
  • 财政年份:
    2019
  • 资助金额:
    $ 17.81万
  • 项目类别:
Scaling-Up Stepped Care for Women's Mental Health in Primary Care in an LMIC
在中低收入国家的初级保健中扩大对妇女心理健康的分级护理
  • 批准号:
    10676331
  • 财政年份:
    2019
  • 资助金额:
    $ 17.81万
  • 项目类别:
Scaling-Up Stepped Care for Women's Mental Health in Primary Care in an LMIC
在中低收入国家的初级保健中扩大对妇女心理健康的分级护理
  • 批准号:
    10001626
  • 财政年份:
    2019
  • 资助金额:
    $ 17.81万
  • 项目类别:

相似海外基金

Scientific Leadership Group Core
科学领导小组核心
  • 批准号:
    10595900
  • 财政年份:
    2023
  • 资助金额:
    $ 17.81万
  • 项目类别:
RP4 LEAP
RP4飞跃
  • 批准号:
    10595904
  • 财政年份:
    2023
  • 资助金额:
    $ 17.81万
  • 项目类别:
RP5 MPT Study
RP5 MPT 研究
  • 批准号:
    10595905
  • 财政年份:
    2023
  • 资助金额:
    $ 17.81万
  • 项目类别:
IAS 2023, the 12th IAS Conference on HIV Science, Brisbane, Australia, and virtually, 23-26 July 2023
IAS 2023,第 12 届 IAS HIV 科学会议,澳大利亚布里斯班,虚拟会议,2023 年 7 月 23-26 日
  • 批准号:
    10696505
  • 财政年份:
    2023
  • 资助金额:
    $ 17.81万
  • 项目类别:
Hermanos de Luna y Sol: A community-based HIV prevention intervention
Hermanos de Luna y Sol:基于社区的艾滋病毒预防干预措施
  • 批准号:
    10626689
  • 财政年份:
    2023
  • 资助金额:
    $ 17.81万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了